Optimal timing for initiation of highly active antiretroviral therapy in treatment-naïve human immunodeficiency virus-1-infected individuals presenting with AIDS-defining diseases: The experience of the PISCIS Cohort

  1. Manzardo, C.
  2. Esteve, A.
  3. Ortega, N.
  4. Podzamczer, D.
  5. Murillas, J.
  6. Segura, F.
  7. Force, L.
  8. Tural, C.
  9. Vilaró, J.
  10. Masabeu, A.
  11. Garcia, I.
  12. Guadarrama, M.
  13. Ferrer, E.
  14. Riera, M.
  15. Navarro, G.
  16. Clotet, B.
  17. Gatell, J.M.
  18. Casabona, J.
  19. Miró, J.M.
Revista:
Clinical Microbiology and Infection

ISSN: 1469-0691,  1198-743X

Any de publicació: 2013

Volum: 19

Número: 7

Pàgines: 646-653

Tipus: Article

DOI: 10.1111/J.1469-0691.2012.03991.X GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus